Protein-Based Biosensors represent a cutting-edge technology that harnesses the unique properties of proteins to detect and quantify various biomolecules. These biosensors rely on the specific binding interactions between proteins and target analytes, enabling sensitive and selective detection. Antibodies, enzymes, and receptors are commonly utilized as recognition elements in protein-based biosensors. Antibodies, for instance, exhibit high specificity for their target molecules, allowing for precise detection in complex biological samples. Enzymatic biosensors leverage the catalytic activity of enzymes to convert the presence of a target molecule into a measurable signal. Receptors, such as G-protein-coupled receptors, enable the detection of diverse analytes. The integration of these proteins into biosensor platforms facilitates real-time monitoring of biochemical processes, making them invaluable in medical diagnostics, environmental monitoring, and food safety applications. Protein-based biosensors offer advantages such as rapid response times, high sensitivity, and the ability to tailor their specificity for a wide range of targets. Ongoing research focuses on enhancing the stability and scalability of these biosensors for widespread use. The versatility and precision of protein-based biosensors position them as powerful tools in advancing our understanding of biological processes and improving diagnostics in diverse fields.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States